Where are peptide ligands of potassium channels sourced from?

IF 3 3区 医学 Q2 PHARMACOLOGY & PHARMACY
Molecular Pharmacology Pub Date : 2026-07-01 Epub Date: 2026-06-08 DOI:10.1016/j.molpha.2026.100135
Alexey I Kuzmenkov, Alexander A Vassilevski
{"title":"Where are peptide ligands of potassium channels sourced from?","authors":"Alexey I Kuzmenkov, Alexander A Vassilevski","doi":"10.1016/j.molpha.2026.100135","DOIUrl":null,"url":null,"abstract":"<p><p>Potassium (K<sup>+</sup>) channels are targeted by a wide range of chemical and biological substances, with peptide ligands standing out due to their exceptional affinity and selectivity. Although most of these molecules belong to venom-derived compounds, novel ligands from various less investigated or less popular sources are being discovered. Application of polypeptides is not restricted to fundamental studies and can be expanded to drug discovery, clinical pharmacology, and pharmaceutics. In this report, we offer a concise overview of the diversity of K<sup>+</sup> channel ligands and their sources, briefly summarizing recent developments in the field and providing an outlook. SIGNIFICANCE STATEMENT: This paper provides a concise overview of the diversity of K<sup>+</sup> channel ligands and their natural sources, highlights recent advances, and outlines future directions. Although venom-derived polypeptides remain the main source, growing interest is focused on nonvenomous organisms such as plants and mammals. We also discuss artificial polypeptides developed using mutagenesis, and the potential of machine learning and neural networks as promising tools for further molecular design.</p>","PeriodicalId":18767,"journal":{"name":"Molecular Pharmacology","volume":"108 7","pages":"100135"},"PeriodicalIF":3.0000,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.molpha.2026.100135","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/6/8 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Potassium (K+) channels are targeted by a wide range of chemical and biological substances, with peptide ligands standing out due to their exceptional affinity and selectivity. Although most of these molecules belong to venom-derived compounds, novel ligands from various less investigated or less popular sources are being discovered. Application of polypeptides is not restricted to fundamental studies and can be expanded to drug discovery, clinical pharmacology, and pharmaceutics. In this report, we offer a concise overview of the diversity of K+ channel ligands and their sources, briefly summarizing recent developments in the field and providing an outlook. SIGNIFICANCE STATEMENT: This paper provides a concise overview of the diversity of K+ channel ligands and their natural sources, highlights recent advances, and outlines future directions. Although venom-derived polypeptides remain the main source, growing interest is focused on nonvenomous organisms such as plants and mammals. We also discuss artificial polypeptides developed using mutagenesis, and the potential of machine learning and neural networks as promising tools for further molecular design.

钾离子通道的肽配体从何而来?
钾(K+)通道是广泛的化学和生物物质的靶标,肽配体因其特殊的亲和力和选择性而脱颖而出。虽然大多数这些分子属于毒液衍生的化合物,但来自各种较少研究或不太流行的来源的新型配体正在被发现。多肽的应用不仅限于基础研究,还可以扩展到药物发现、临床药理学和药剂学。在本报告中,我们简要概述了K+通道配体的多样性及其来源,简要总结了该领域的最新发展并提供了展望。意义声明:本文简要概述了K+通道配体的多样性及其天然来源,重点介绍了最近的进展,并概述了未来的发展方向。虽然毒液衍生多肽仍然是主要来源,但越来越多的兴趣集中在无毒生物,如植物和哺乳动物上。我们还讨论了利用诱变技术开发的人工多肽,以及机器学习和神经网络作为进一步分子设计的有前途的工具的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Molecular Pharmacology
Molecular Pharmacology 医学-药学
CiteScore
7.20
自引率
2.80%
发文量
50
审稿时长
3-6 weeks
期刊介绍: Molecular Pharmacology publishes findings derived from the application of innovative structural biology, biochemistry, biophysics, physiology, genetics, and molecular biology to basic pharmacological problems that provide mechanistic insights that are broadly important for the fields of pharmacology and toxicology. Relevant topics include: Molecular Signaling / Mechanism of Drug Action Chemical Biology / Drug Discovery Structure of Drug-Receptor Complex Systems Analysis of Drug Action Drug Transport / Metabolism
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书